Endovia Health Sciences EDVA Cash Flow Statement (2012-2026)

NYSE EDVA
$0.26 0.00 (-0.04%)
As of: Sep 3, 2026 · 11:34 AM EDT
Reported Financials

Endovia Health Sciences Quarterly Cash Flow Statement

Periods 58 quarters
Latest Jun 2026

Endovia Health Sciences reported cash from operations of -$1.09M and free cash flow of -$1.09M for the quarter ended Jun 2026, down 98.1% year over year. This cash flow statement covers 58 quarters of results from Mar 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-12.19M-6.18M-5.91M-5.69M-5.08M-4.79M-3.45M-4.22M-4.32M-4.58M-3.78M-4.31M-3.56M-1.95M-2.90M-8.49M-9.86M-1.92M-2.14M-2.28M
Share-based CompensationStock Comp.
17.32M-2.25M2.36M2.72M2.04M0.21M0.22M0.86M0.14M-0.05M0.56M1.34M0.19M0.26M0.14M0.05M7.75M0.56M0.18M1.11M
Cash from Discontinued OperationsCash from Discont. Ops
0.02M-0.30M0.22M-0.22M-0.03M
Non-cash ItemsNon-Cash Items
0.70M0.70M2.30M1.50M0.90M1.10M
Cash from OperationsCash from Ops.
-3.94M-3.08M-4.68M-2.43M-3.72M-3.22M-4.10M-2.42M-1.98M-1.69M-1.31M-2.43M-2.65M-0.92M-0.81M-0.55M-2.47M-0.99M-0.93M-1.09M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-0.09M0.00M-795.00427.00189.000.00M21.0021.0021.00-231.000.01M0.00M-997.00-0.00M-0.02M-0.00M-0.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.04M-0.01M0.21M0.05M0.05M0.63M0.13M0.14M0.14M0.14M0.14M0.14M0.14M-0.00M0.00M0.00M0.11M-0.10M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.02M-0.09M0.28M0.22M-0.13M0.33M0.38M-0.24M-0.44M-0.62M-0.13M-0.09M-0.07M-0.04M-0.12M-0.03M-0.11M0.08M0.00M-0.01M
Change in InventoryChange Inventory
0.29M0.39M0.13M0.59M0.94M0.14M-0.58M0.30M-0.54M-0.65M-0.78M-0.17M0.04M0.32M-0.03M-0.01M0.00M-0.25M0.02M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
-0.48M0.65M0.10M0.14M0.49M0.86M-0.46M0.17M0.83M1.05M0.51M0.13M0.78M0.93M1.14M1.03M-0.66M0.07M0.84M-0.05M
Investing Activities
Capital ExpendituresCapex
0.05M0.06M0.01M0.00M0.00M0.00M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
Acquisitions
Divestments
Cash from Investing ActivitiesCash from Investing
-0.05M-0.06M-0.01M-0.00M-0.00M0.00M-0.00M
Financing Activities
Other financing activitiesOther financing
-0.25M0.12M0.11M0.05M-39.00-78.00
Cash from Financing ActivitiesCash from Financing
0.12M-0.58M8.77M-1.63M2.16M5.16M1.83M1.19M1.15M1.98M0.95M2.42M3.01M1.16M0.76M0.70M2.67M0.98M1.05M1.16M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
3.93M
Net Equity Issued and RepurchasedNet Equity Issued
9.20M-1.13M2.74M0.62M0.15M0.50M1.37M1.58M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
Additional items
Exchange Rate EffectFX Effect
-0.02M-0.00M-0.02M0.03M-0.01M-0.01M182.000.09M0.02M-0.05M0.00M-0.00M-175.00-0.02M0.00M
Change in Cash
-3.80M-3.96M4.31M-4.29M-1.60M1.83M-2.29M-1.24M-0.81M0.28M-0.37M-0.01M0.45M-0.23M-0.02M0.02M0.25M0.02M0.10M-0.14M
Free Cash FlowFCF
-3.94M-3.08M-4.68M-2.43M-3.76M-3.27M-4.11M-2.42M-1.98M-1.69M-1.31M-2.43M-2.65M-0.92M-0.81M-0.55M-2.47M-0.99M-0.93M-1.09M
Net Cash FlowNCF
-3.82M-3.67M4.09M-4.06M-1.60M1.88M-2.28M-1.23M-0.84M0.29M-0.36M-0.01M0.36M0.24M-0.05M0.15M0.20M-0.01M0.12M0.06M